Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001493152-22-022572
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$622.35K | -$1.14M | -$928.60K | -$130.29K |
| EPS Diluted | -$0.01 | -$0.01 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end
